Chronic kidney disease (CKD) has been called an “under-recognized public health crisis,” and is estimated to impact 14% of US adults. CKD patients typically have to undergo regular dialysis treatment ... McKnight's Long-Term Care News: Group updates chronic kidney disease treatment guidelines for first time since 2012 The Kidney Disease: Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults.
A JAMA article published Wednesday ... Group updates chronic kidney disease treatment guidelines for first time since 2012 The 9th Annual Patient Symposium offers educational seminars on dialysis, nutrition, mental health and treatment options, with 1.2 million Ohioans affected by kidney disease. MarketWatch: Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight -- Leading chronic kidney disease companies, such as AstraZeneca, Boehringer Ingelheim, Mineralys Therapeutics, ProKidney, Disc Medicine, Regeneron Pharmaceuticals, AION Healthspan, Amgen, Maze ... Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
